DexCom (NASDAQ:DXCM)
Dollar Amount of Shares Sold: $50,659,864.27
Number of Insider Stock Sales in the Last 180 Days: 40
Volume of Shares Sold: 164,453
Who Sold Shares: Andrew K Balo (Insider), Barbara Kahn (Director), Donald Abbey (EVP), Heather S Ace (SVP), Jacob Steven Leach (EVP), Jeffrey Moy (EVP), Jereme M Sylvain (CAO), Kevin R Sayer (CEO), Nicholas Augustinos (Director), Patrick Michael Murphy (EVP), Patrick Michael Murphy (Insider), Patrick Michael Murphy (SVP), Quentin S Blackford (CFO), Richard Alexander Collins (Director), Richard Doubleday (EVP), Shelly Ramasamy Selvaraj (SVP) and Steven Robert Pacelli (EVP)
DexCom, Inc, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system.
Read More
